Is multiple myeloma turning into a chronic manageable disease?
Multiple Myeloma: Turning a Once-Deadly Disease into a Manageable Disease June 15 forum will detail latest treatments to combat this cancer of the elderly SEATTLE — Jun. 9, 2004 — Science is increasingly commuting the death sentence that is a diagnosis of multiple myeloma. A cancer of the plasma cells that primarily strikes the elderly, multiple myeloma has been deadly because patients have been unable to withstand the aggressive treatment necessary to combat it. Now that’s changing with the use of new drugs combined with refinements in the use and timing of stem cell transplants — therapies minus the devastating side effects of traditional treatment. Details of the latest therapies for multiple myeloma will be discussed during a unique “town meeting” style program June 15 at Fred Hutchinson Cancer Research Center sponsored by the Leukemia & Lymphoma Society. The free program, open to the general public, is accessible in person, via a live Webcast (or later by Web archive) or by a toll
